We noted a trend toward a lower incidence of CMV infection in recipients who carried the KIR B/X genotype (n = 30 [31.2%]) compared with the KIR A/A genotype (n = 20 [47.6%]). This evidence concerns the gene KIR3DL1 and cytomegalovirus infection.